SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-317328
Filing Date
2013-08-02
Accepted
2013-08-02 16:53:11
Documents
13
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d543609d10q.htm 10-Q 493400
2 EX-10.3 d543609dex103.htm EX-10.3 3241
3 EX-21.1 d543609dex211.htm EX-21.1 1942
4 EX-31.1 d543609dex311.htm EX-31.1 10111
5 EX-31.2 d543609dex312.htm EX-31.2 10570
6 EX-32.1 d543609dex321.htm EX-32.1 6573
13 GRAPHIC g543609g26v91.jpg GRAPHIC 1886
  Complete submission text file 0001193125-13-317328.txt   4317528

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snss-20130630.xml EX-101.INS 450028
8 XBRL TAXONOMY EXTENSION SCHEMA snss-20130630.xsd EX-101.SCH 33457
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20130630_cal.xml EX-101.CAL 49623
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20130630_def.xml EX-101.DEF 75090
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20130630_lab.xml EX-101.LAB 246394
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20130630_pre.xml EX-101.PRE 157674
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 131007007
SIC: 2834 Pharmaceutical Preparations